Correlations of Hippocampal Atrophy and Focal Low-Frequency Magnetic Activity in Alzheimer Disease: Volumetric MR Imaging-Magnetoencephalographic Study

References

1. ↵
   Jagust WJ, Budinger TF, Reed B. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987;44:258–262

   CrossRefPubMedWeb of Science
2. Jagust WJ, Eberling JL, Reed BR, Mathis CA, Budinger TF. Clinical studies of cerebral blood flow in Alzheimer’s disease. Ann NY Acad Sci 1997;826:254–262

   PubMedWeb of Science
3. Jagust WJ, Haan MN, Reed BR, Eberling JL. Brain perfusion imaging predicts survival in alzheimer’s disease. Neurology 1998;51:1009–1013

   Abstract/FREE Full Text
4. Neary D, Snowden JS, Shields RA. Single photon emission tomography using ^99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101–1119

   Abstract/FREE Full Text
5. ↵
   Talbot PR, Lloydd JJ, Snowden JS. A clinical role for ^99mTc-HM-PAO SPECT in the investigation of dementia? J Neurol Neurosurge Psychiatry 1998;64:306–313

   Abstract/FREE Full Text
6. Masterman DL, Mendez MF, Fairbanks LA. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer’s disease from other dementias. J Geriatr Psychiatry Neurol 1997;10:15–21
7. ↵
   Rapoport SI. Positron emission tomography in Alzheimer’s disease in relation to disease pathogenesis: a critical review. Cerebrovasc Brain Metab 1991;3:297–335
8. ↵
   Van Gool WA, Walstra GJ, Teunisse S. Diagnosing Alzheimer’s disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J Neurol 1995;242:401–405

   CrossRefPubMedWeb of Science
9. ↵
   Buchan RJ, Nagata K, Yokoyama E, et al. Regional correlations between the EEG and oxygen metabolism in dementia of the Alzheimer’s type. Electroencephalogr Clin Neurophysiol 1997;103:409–417

   CrossRefPubMedWeb of Science
10. ↵
    Dierks T, Jelic V, Pascual-Marqui RD, et al. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer disease. Clin Neurophysiol 2000;111:1817–1824

    CrossRefPubMedWeb of Science
11. ↵
    Matousek M, Brunovsky M, Edman A, Wallin A. EEG abnormalities in dementia reflect the parietal lobe syndrome. Clin Neurophysiol 2001;112:1001–1005

    CrossRefPubMed
12. ↵
    Jonkman EJ. The role of the electroencephalogram in the diagnosis of dementia of the Alzheimer type: an attempt at technology assessment. Neurophysiol Clin 1997;27:211–219

    CrossRefPubMed
13. ↵
    De Carli C, Murphy DGM, Mc Intosh AR, Teichberg D, Schapiro MB, Horwitz B. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res 1995;57:119–130

    CrossRefPubMedWeb of Science
14. Laakso MP, Soininen H, Partanen K. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer’s disease: correlation with memory functions. J Neural Transm 1995;9:73–86
15. ↵
    Kidron D, Black SE, Stanchev P, et al. Quantitative MR volumetry in Alzheimer’s disease. Topographic markers and the effect of sex and education. Neurology 1997;49:1504–1512

    Abstract/FREE Full Text
16. ↵
    Juottonen K, Laakso MP, Partanen K, Soininen H. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 1999;20:139–144

    Abstract/FREE Full Text
17. ↵
    Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F. Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol 2000;47:430–439

    CrossRefPubMedWeb of Science
18. ↵
    Yamaguchi S, Meguro K, Itoh M, et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer’s disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 1997;62:596–600

    Abstract/FREE Full Text
19. ↵
    Claus JJ, Ongerboer De Visser BW, et al. Determinants of quantitative spectral electroencephalography in early Alzheimer’s disease: cognitive function, regional cerebral blood flow, and computed tomography. Dementia Geriatr Cogn Disord 2000;11:81–89
20. ↵
    Elbert T. Neuromagnetism. In: Andrä W, Nowak H, eds. Magnetism in Medicine. New York: J Wiley & Sons,1998;190–262
21. ↵
    Vieth J, Kober H, Grummich P. Slow wave and beta wave activity associated with white matter structural brain lesions, localized by the dipole density plot. In: Baumgartner C, Deecke L, Stroink G, Willianson SJ, eds. Biomagnetism: Fundamental Research and Clinical Applications. Amsterdam: Elsevier/IOS-Press;1995;50–54
22. ↵
    Fernández A, Maestú F, Amo C, et al. Focal temporo-parietal slow activity in Alzheimer’s disease revealed by magnetoencephalography. Biol Psychiatry. In press.
23. ↵
    McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984;34:939–944

    Abstract/FREE Full Text
24. ↵
    Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988;24:653–659

    PubMedWeb of Science
25. ↵
    Roth M, Huppert FA, Tym E, Mountjoy CQ. CAMDEX, the Cambridge Examination for Mental Disorders of the Elderly. Cambridge: Cambridge University Press;1988
26. ↵
    Lobo A, Ezquerra V. El mini-examen cognoscitivo: un test sencillo y práctico para detectar alteraciones intelectivas en pacientes médicos. Actas Luso-Español Psiquiatría Psicol Méd 1979;3:189–202
27. ↵
    Oppenhein AV, Schafer RW. Digital Signal Processing. Englewood Cliffs: Prentice-Hall;1974
28. ↵
    Fehr T, Kissler J, Moratti S, Wienbruch C, Rockstroh B, Elbert T. Source distribution of neuromagnetic slow waves and MEG-delta activity in Schizophrenic patients. Biol Psychiatry 2001;50:108–116

    CrossRefPubMedWeb of Science
29. ↵
    Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001;22:1483–1489

    Abstract/FREE Full Text
30. ↵
    Mori E, Yoneda Y, Yamashita H, Hirono N, Ikeda M, Yamadori A. Medial temporal structures relate to memory impairment in Alzheimer’s disease. J Neurol, Neurosurg Psychiatry 1997;63:214–221

    Abstract/FREE Full Text
31. ↵
    Thompson PM, Mega MS, Woods RP, et al. Cortical change in Alzheimer’s disease detected with a disease-specific population-based brain atlas. Cereb Cortex 2001;11:1–16

    Abstract/FREE Full Text
32. ↵
    Ohmishi T, Matsuda H, Tabira T, Asada T, Uno M. Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 2001;22:1680–1685

    Abstract/FREE Full Text
33. ↵
    Jack CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzhimer’s disease. Neurology 1997;49:786–794

    Abstract/FREE Full Text
34. Lehericy S, Baulac M, Chiras J Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:927–937
35. Convit A, De León MJ, Golomb J, George AE. Hippocampal atrophy in early Alzheimer’s disease: anatomic specificity and validation. Psychiatry Q 1993;64:371–387

    CrossRef
36. ↵
    Convit A, De León MH, Tarshish C. Hippocampal volume losses in minimally impaired elderly. Lancet 1995;345:266

    PubMedWeb of Science
37. ↵
    Förstl H, Besthorn C, Sattle H, et al. Volumetric brain changes and quantitative EEG in normal aging and Alzheimer’s disease. Nervenarzt 1996;67:53–61

    PubMed
38. ↵
    Berendse HW, Verbunt JPA, Scheltens P, Van Dijk BW, Jonkman EJ. Magnetoencephalographic analysis of cortical activity in Alzheimer’s disease: a pilot study. Clin Neurophisiol 2000;111:604–612

    CrossRef
39. ↵
    Lavenex P, Amaral DG. Hippocampal-neocortical interaction: a hierarchy of associativity. Hippocampus 2000;10:420–430

    CrossRefPubMedWeb of Science